Medicinalproductdefinition-example-equilidem-basics.xml

Basic details of a product, only using MedicinalProductDefinition and no other resources (id = "equilidem-basics")

<?xml version="1.0" encoding="UTF-8"?>

<MedicinalProductDefinition xmlns="http://hl7.org/fhir">
  <id value="equilidem-basics"/> 
  <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"><p> <b> Generated Narrative</b> </p> <p> <b> id</b> : equilidem-basics</p> <p> <b> identifier</b> : id: Equilidem25</p> <p> <b> combinedPharmaceuticalDoseForm</b> : <span> tablet</span> </p> <p> <b> indication</b> : Prevention of venous thromboembolic events (VTE) in adult patients who have undergone
         elective hip or knee replacement surgery. Prevention of stroke and systemic embolism in
         adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors,
         such as prior stroke or transient ischaemic attack (TIA); age ≥ 75 years; hypertension;
         diabetes mellitus; symptomatic heart failure (NYHA Class &gt;= II). Treatment of deep
         vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and
         PE in adults.</p> <p> <b> legalStatusOfSupply</b> : <span> Prescription only medicine</span> </p> <p> <b> classification</b> : <span> B01A</span> </p> <p> <b> ingredient</b> : </p> <ul> <li> <span> Equilidonium Phosphate</span> </li> <li> <span> Calcium Carbonate</span> </li> </ul> <h3> Names</h3> <table> <tr> <td> -</td> <td> <b> ProductName</b> </td> </tr> <tr> <td> *</td> <td> Equilidem 2.5 mg film-coated tablets</td> </tr> </table> <h3> CrossReferences</h3> <table> <tr> <td> -</td> <td> <b> Product</b> </td> </tr> <tr> <td> *</td> <td/>  </tr> </table> <h3> ManufacturingBusinessOperations</h3> <table> <tr> <td> -</td> <td> <b> Manufacturer</b> </td> </tr> <tr> <td> *</td> <td> <span> EquiliDrugCo Inc.</span> </td> </tr> </table> </div> </text> <identifier> 
    <system value="http://example.org.uk/fhir/product"/> 
    <value value="Equilidem25"/> 
  </identifier> 
  <combinedPharmaceuticalDoseForm> 
    <coding> 
      <system value="http://example.org.uk/fhir/dosefom"/> 
      <code value="tablet"/> 
    </coding> 
  </combinedPharmaceuticalDoseForm> 
  <indication value="Prevention of venous thromboembolic events (VTE) in adult patients who have undergone
   elective hip or knee replacement surgery. Prevention of stroke and systemic embolism in
   adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors,
   such as prior stroke or transient ischaemic attack (TIA); age ≥ 75 years; hypertension;
   diabetes mellitus; symptomatic heart failure (NYHA Class &gt;= II). Treatment of deep
   vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and
   PE in adults."/> 
  <legalStatusOfSupply> 
    <coding> 
      <system value="http://example.org.uk/fhir/legalstatusofsupply"/> 
      <code value="POM"/> 
      <display value="Prescription only medicine"/> 
    </coding> 
  </legalStatusOfSupply> 
  <classification> 
    <coding> 
      <system value="http://www.whocc.no/atc/example"/> 
      <code value="B01A"/> 
    </coding> 
  </classification> 
  <ingredient> 
    <display value="Equilidonium Phosphate"/> 
  </ingredient> 
  <ingredient> 
    <display value="Calcium Carbonate"/> 
  </ingredient> 
  <name> 
    <productName value="Equilidem 2.5 mg film-coated tablets"/> 
  </name> 
  <crossReference> 
    <product> 
      <reference> 
        <reference value="MedicinalProductDefinition/genericEquilidonium"/> 
      </reference> 
    </product> 
  </crossReference> 
  <manufacturingBusinessOperation> 
    <manufacturer> 
      <display value="EquiliDrugCo Inc."/>  <!--    licence holder would use RegulatedAuthorization    -->
    </manufacturer> 
  </manufacturingBusinessOperation> 
</MedicinalProductDefinition>